1. Home
  2. LEE vs ASRT Comparison

LEE vs ASRT Comparison

Compare LEE & ASRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lee Enterprises Incorporated

LEE

Lee Enterprises Incorporated

HOLD

Current Price

$7.86

Market Cap

160.1M

ML Signal

HOLD

Logo Assertio Holdings Inc.

ASRT

Assertio Holdings Inc.

BUY

Current Price

$13.36

Market Cap

76.0M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
LEE
ASRT
Founded
1890
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Newspapers/Magazines
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
160.1M
76.0M
IPO Year
2025
2004

Fundamental Metrics

Financial Performance
Metric
LEE
ASRT
Price
$7.86
$13.36
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$35.00
AVG Volume (30 Days)
116.8K
42.2K
Earning Date
05-07-2026
03-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$543,955,000.00
$118,713,000.00
Revenue This Year
$5.48
N/A
Revenue Next Year
N/A
$16.87
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.34
$0.51
52 Week High
$11.21
$13.90

Technical Indicators

Market Signals
Indicator
LEE
ASRT
Relative Strength Index (RSI) 46.36 66.87
Support Level $3.77 $0.69
Resistance Level $9.74 N/A
Average True Range (ATR) 0.77 0.65
MACD -0.24 0.14
Stochastic Oscillator 0.00 78.95

Price Performance

Historical Comparison
LEE
ASRT

About LEE Lee Enterprises Incorporated

Lee Enterprises Inc is a local news publication company in the United States. It is a digital-first subscription business providing local markets with valuable, high-quality, trusted, intensely local news, information, advertising, and marketing services. The product portfolio of the company includes digital subscription platforms, daily, weekly, and monthly newspapers, and niche products, all delivering original local news and information as well as national and international news. The products offer digital and print editions, and content and advertising are available in real-time through the websites and mobile apps.

About ASRT Assertio Holdings Inc.

Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.

Share on Social Networks: